Last reviewed · How we verify

omeprazole/sodium bicarbonate — Competitive Intelligence Brief

omeprazole/sodium bicarbonate (omeprazole/sodium bicarbonate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Proton pump inhibitor with antacid. Area: Gastroenterology.

marketed Proton pump inhibitor with antacid H+/K+-ATPase (proton pump) Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

omeprazole/sodium bicarbonate (omeprazole/sodium bicarbonate) — Food and Drug Administration (FDA). Omeprazole inhibits gastric acid secretion by blocking the proton pump in stomach parietal cells, while sodium bicarbonate provides rapid acid neutralization.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
omeprazole/sodium bicarbonate TARGET omeprazole/sodium bicarbonate Food and Drug Administration (FDA) marketed Proton pump inhibitor with antacid H+/K+-ATPase (proton pump)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Proton pump inhibitor with antacid class)

  1. Food and Drug Administration (FDA) · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). omeprazole/sodium bicarbonate — Competitive Intelligence Brief. https://druglandscape.com/ci/omeprazole-sodium-bicarbonate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: